National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
IN THIS ISSUE
The Latest Advances in Lymphoma Research

Multiple Myeloma

Animation/VideoAnimation/Video

Audio ClipsAudio Clips

Photos/StillsPhotos/Stills

USEFUL CANCER BACKGROUND
Understanding Cancer Series
Show-and-Tell Tutorials

------

NCI Fact Sheets
Briefs on Cancer Topics

------

NewsCenter
Press Releases

------
SEARCH BENCHMARKS
   
  Between these Dates:      
     
     
Search Benchmarks  
    View All Issues  

MEDIA RESOURCES
Noticias En Español

Understanding Cancer Series

Visuals Online

B-Roll Footage

Radio Broadcasts

Entertainment Resources

Go To Benchmarks Home Page...
Benchmarks
------
Volume 5, Issue 3
------
Audio

TRANSCRIPT: Dr. Wyndham Wilson, NCI, discusses lymphomas vs. leukemias.


Q: Why are there more cancers of the lymphatic system than of the vascular system?

A: Probably because lymphomas are a disease of lymphocytes. Anytime a cell starts to divide, it's at higher risk of getting additional hits. In contrast with a myeloid cell, the myeloid cell is there. But you have a system like the lymphoid system where our lymphoid cells are. What they do for a living is they just divide and stimulate constantly, constantly, constantly. And I think the sheer number of all these different things going on just puts them at higher risk.

In fact, we know from a conceptual point of view that that is in fact a risk. Because if you look at autoimmune disorders, where there is an abnormal activation of the immune system, it's usually lymphocytes against a normal target. Those patients all have an increased risk of getting lymphoid diseases.


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov